Drug giant Merck said it will buy Cubist Pharmaceuticals for about $9.5 billion, or $102 a share in cash, bringing Merck a slate of medicines administered in the hospital setting, many for bacterial ...

The very day Merck & Co. Inc. (MRK) announced its intention to acquire Cubist Pharmaceuticals Inc. (CBST) in an all-cash transaction valued at about $9.5 billion or $102 per share, the U.S. District ...

The battle against emerging "superbugs" is producing a new generation of antibiotics. Now it has also produced a giant payout for a Lexington biotech on the front lines of the effort to take on ...

Two paintings by Diego Rivera, including his 1915 Cubist masterpiece, have joined “Picasso & Rivera: Conversations Across Time,” an exhibition at the Los Angeles County Museum of Art that opened in ...

Merck has announced that it will acquire Cubist Pharmaceuticals for $8.4 billion. This year has been busy with M&A (mergers and acquisitions) activity in the pharmaceutical industry and Merck has been ...

Cubism was one of the most influential art movements that came up in the early 20th century. Artists like Pablo Picasso and Georges Braque were the pioneers of this movement and for their time, they ...

Monday - Friday, 6:00 - 7:00 PM ET If there is one person who couldn't be more excited by Merck 's acquisition of Cubist Pharma, it's Jim Cramer. "I think this morning's purchase of Cubist Pharma for ...

Shares of Cubist Pharmaceuticals (CBST) soared 36% Monday after Merck (MRK) announced it's buying the Cambridge, Mass. drugmaker for $102 per share. Cubist Pharmaceuticals Inc. does advanced ...

Adolor stockholders will receive $4.35 cash per share and one CPR worth up to $4.50 per share, dependent on approval of opioid-associated constipation candidate. Adolor’s stock price shot up 130% this ...